Drug intelligence / Profile preview

technetium-99m-tin colloid

Development stage
Unknown
Lead developer
Brookhaven National Laboratory
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Subcutaneous
01

Overview

Technetium-99m-tin colloid is a radiopharmaceutical diagnostic agent used in nuclear medicine imaging. It consists of technetium-99m, a metastable nuclear isomer that emits gamma rays detectable by gamma cameras, bound to a tin-based colloidal particle. After administration (typically intravenous or subcutaneous), the tin colloid particles are phagocytosed by cells of the reticuloendothelial system—primarily in the liver, spleen, and bone marrow—allowing for imaging of these organs and assessment of their function. The mechanism relies on passive uptake by reticuloendothelial cells rather than specific receptor binding or enzymatic action. Technetium-99m has favorable properties for medical imaging due to its short half-life (about 6 hours) and emission of low-energy gamma radiation suitable for detection with minimal patient radiation exposure[4][5][8]. The primary indications include evaluation of liver and spleen morphology and function, bone marrow imaging, lymphoscintigraphy (sentinel lymph node mapping), and occasionally studies related to gastrointestinal transit.

Brand names
Hepatate
Other names
technetium-99m tin colloidtechnetium99m tin colloidtechnetium 99m tin colloidTc-99m tin colloidTc99m tin colloidTc 99m tin colloid

Beyond the preview

Go deeper on technetium-99m-tin colloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium-99m-tin colloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call